Among them, small-cell lung cancer, the IL-17 signaling pathway, pathways in cancer, prostate cancer, the P53 signaling pathway, the TNF signaling pathway, the VEGF signaling pathway, and the estrogen signaling pathway were the most significantly enriched pathways. This evidence concerns the gene IL17A and prostate carcinoma.